Kovina Therapeutics: Funding, Investors & Team (Sep 2026)
Kovina Therapeutics works as a pre-clinical biotechnology organization intends to find a non-careful, clinical therapy for Human Papillomavirus (HPV) contaminations and tumors.
Kovina Therapeutics has raised $580k across 3 funding rounds on record, the most recent an undisclosed round of $280k announced in Nov 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kovina Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Kovina Therapeutics Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Kovina Therapeutics announced a Grant in Jun 2022; the amount was not disclosed.
3 months later, a Grant of $300k was announced in Sep 2022.
2 months later, an undisclosed round of $280k was announced in Nov 2022.
Kovina Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Kovina Therapeutics Funding Compared to Other Biotechnology Startups
Kovina Therapeutics' latest round of $280k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kovina Therapeutics in Biotechnology and Indianapolis
Companies Similar to Kovina Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Kovina Therapeutics Funding FAQs
What does Kovina Therapeutics do?
Kovina Therapeutics works as a pre-clinical biotechnology organization intends to find a non-careful, clinical therapy for Human Papillomavirus (HPV) contaminations and tumors.
How much funding has Kovina Therapeutics raised?
Kovina Therapeutics has raised $580k across 3 rounds on record. The most recent is an undisclosed round of $280k announced in Nov 2022.
When did Kovina Therapeutics last raise funding?
Kovina Therapeutics' most recent funding round on record is an undisclosed round of $280k, announced in Nov 2022.
Who founded Kovina Therapeutics?
FundedIQ lists Elliot Androphy (Founder), Samy Meroueh (Founder) at Kovina Therapeutics.
Where is Kovina Therapeutics headquartered?
Kovina Therapeutics is based in Indianapolis, Indiana, United States.
How many employees does Kovina Therapeutics have?
Kovina Therapeutics is in the 1-10 employee band.
How does Kovina Therapeutics' funding compare to other Biotechnology startups?
Kovina Therapeutics' latest round of $280k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Kovina Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kovina Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.